Critically, the eIF4Fi-induced increase in EGR1 and c-Fos protein levels was entirely abrogated by the specific MEK inhibitor PD184352, confirming the complete dependence of the induced c-Fos and EGR1 overexpression in BRAFV600E melanoma cells on the ERK pathway activity. The gene discussed is MAP2K7; the disease is melanoma.